ArticleViruses2023

Atovaquone and Pibrentasvir Inhibit the SARS-CoV-2 Endoribonuclease and Restrict Infection In Vitro but Not In Vivo.

Troy von Beck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.